Typhoid fever in group travelers: Opportunity for studying vaccine efficacy

Journal of Travel Medicine

Volumn 7, Issue 1, 2000, Pages 19-24

  Cobelens, Frank G J ^a   Kooij, Saskia ^a   Warris Versteegen, Anita ^b   Visser, Leo G ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Ministry of Health Welfare and Sport Netherlands   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE;

ADULT; ARTICLE; BACTERIUM ISOLATE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; SALMONELLA TYPHI; TRAVEL; TYPHOID FEVER;

EID: 0034005155     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00005     Document Type: Article

References (19)

1. Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156:84-90.
2. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994. Changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158:663-668.
3. Van Kessel RPM, Visser LG. Enkele importziekten bij reizigers met een korte verblijfsduur in de tropen (Some imported infections in short-term travellers to the tropics). Ned Tijdschr Med Microbiol 1996; 4:80-83.
4. Christenson B, Andersson Y. Typhoid fever among Swedish visitors to Kos in 1983. J Infect 1985; 10:223-227.
5. Engels EA, Falagas ME, Lau J, Bennish ML. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ 1998;316:110-116.
6. Murphy JR, Grez L, Schlesinger L, et al. Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun 1991;59:4291-4293.
7. Forrest BD, LaBrooy JT, Beyer L, et al. The human humoral immune response to Salmonella typhi Ty21a. J Infect Dis 1991; 163:336-345.
8. Preston N. Typhoid vaccine and laboratory indicators of clinical protection. Lancet 1992; 339:555.
9. Viret JF, Cryz SJ. Protective immunity induced by typhoid fever and vaccination. Southeast Asian J Trop Med Public Health 1995; 26(Suppl 2):150-159.
10. Schwartz E, Shlim D, Eaton M, et al. The effect of oral and parenteral vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med 1990; 150:349-351.
11. Woodruff BA, Chen RT. Oral typhoid vaccination for travelers. Arch Intern Med 1991; 151:619-620.
12. Guinée PAM, van Leeuwen WJ. Phage typing of Salmonella. In: Bergan T, Norris JR, eds. Methods in Microbiology. Vol. 11. London: Academic Press, 1978.
13. Guinée PAM, Jansen WH, Maas HME , et al. An unusual H antigen (z66) in strains of Salmonella typhi. Ann Microbiol (Inst.Pasteur) 1981; 132 A:331-334.
14. Benenson AS. Control of communicable diseases manual. 16th Ed. Washington, DC. American Public Health Association, 1995:502-507.
15. Giesecke J. Modern infectious disease epidemiology. London. Edward Arnold, 1994:124-138.
16. Pearson RD, Guerrant RL. Enteric fever and other causes of abdominal symptoms with fever. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th Ed. New York. Churchill Livingston, 1995:998-1012.
17. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055-1068.
18. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986: 86-87.
19. Kaplan DT, Hill DR. Compliance with live, oral Ty21a typhoid vaccine. JAMA 1992; 267:1074.